Related Experiment Video
Updated: May 23, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Getting to the root of hydrocephalus
1Department of Neurosurgery and Division of Pediatric Neurosurgery, University of Utah, Salt Lake City, USA. pat.mcallister@hsc.utah.edu
Lysophosphatidic acid, a lipid carried in the blood, plays a role in fetal-onset hydrocephalus. This finding offers new insights into a serious neurological condition affecting newborns.
Area of Science:
- Neuroscience
- Developmental Biology
- Biochemistry
Background:
- Fetal-onset hydrocephalus is a severe neurological disorder in newborns.
- The precise molecular mechanisms underlying its development are not fully understood.
Purpose of the Study:
- To investigate the role of the blood-borne lipid lysophosphatidic acid (LPA) in the pathogenesis of fetal-onset hydrocephalus.
Main Methods:
- Utilized molecular biology techniques to analyze LPA signaling pathways.
- Investigated the expression and function of LPA receptors in relevant fetal tissues.
Main Results:
- Demonstrated that lysophosphatidic acid significantly contributes to the development of fetal-onset hydrocephalus.
- Identified specific LPA receptor pathways involved in this process.
Conclusions:
- Lysophosphatidic acid and its receptor signaling are critical factors in fetal-onset hydrocephalus.
- Targeting LPA pathways may offer potential therapeutic strategies for this neonatal neurological disorder.
Related Concept Videos
Anatomy of the Brain: Ventricles
Brain Abscess l: Introduction
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology

